{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T15:13:09Z","timestamp":1776265989614,"version":"3.50.1"},"reference-count":38,"publisher":"Centre for Evaluation in Education and Science (CEON\/CEES)","issue":"4","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/BY\/4.0"}],"funder":[{"name":"Guiding Project of Quzhou Science and Technology Bureau"},{"name":"Shen Xian Expert Workstation Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Biochemistry"],"published-print":{"date-parts":[[2026]]},"abstract":"<jats:p>Background: To investigate the potential therapeutic benefits of autoimmune antibody detection in individuals suffering from chronic hepatitis B. Methods: In the observation group, 102 patients with chronic hepatitis B who were admitted between March 2022 and March 2025 were included. Additionally, the control group consisted of 102 healthy people who were examined throughout the same time period. The two groups' autoimmune antibodies were identified, and patients in the observation group with either positive or negative autoimmune antibodies were compared in terms of liver function, liver fibrosis markers, and cytokine levels. Results: The total positive rate of autoimmune antibodies in the observation group was 26.47%, whereas it was 3.92% in the control group (P&amp;lt;0.05). Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels were noticeably greater in patients in the observation group with positive autoimmune antibodies than in those with negative antibodies. However, the albumin (ALB) and total protein (TP) levels were much lower in these patients than in patients with negative antibodies. A statistically significant difference was observed (P&amp;lt; 0.05). The levels of type III procollagen (PCIII), hyaluronidase (HA), and laminin (LN) were significantly (P&amp;lt;0.05) greater in individuals with positive autoimmune antibodies than in those with negative antibodies. Patients with positive autoimmune antibodies had considerably higher levels of interleukin-4 (IL-4), interleukin-10 (IL-10), and interleukin-6 (IL-6) than patients with negative antibodies. Patients who were negative for antibodies had significantly higher levels of interferon-y (IFN-y) (P&amp;lt;0.05). Conclusions: Autoimmune antibodies, which influence liver fibrosis indicators and related cytokines, are present in patients with chronic hepatitis B. The identification of autoimmune antibodies in chronic hepatitis B patients can serve as a guide for evaluating illness and determining patient prognosis.<\/jats:p>","DOI":"10.5937\/jomb0-60938","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:25:12Z","timestamp":1761560712000},"page":"749-756","source":"Crossref","is-referenced-by-count":0,"title":["Correlation analysis of Th1\/Th2 cytokines and liver fibrosis indicators in chronic hepatitis B patients"],"prefix":"10.5937","volume":"45","author":[{"given":"Chun","family":"Yu","sequence":"first","affiliation":[{"name":"The Quzhou Affiliated Hospital of Wenzhou Medical University, Department of Gastrointestinal Surgery, Quzhou City, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiling","family":"Chen","sequence":"additional","affiliation":[{"name":"Western Theatre Command Air Force Hospital, Department of Laboratory Medicine, Chengdu City, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaonan","family":"Han","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Zhejiang University School of Medicine, Department of Gastroenterology, Hangzhou City, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhang","family":"Feng","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Zhejiang University School of Medicine, Department of Gastroenterology, Hangzhou City, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Sun","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Wenzhou Medical University, Department of Hepatobiliary Surgery, Wenzhou City, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Yang","sequence":"additional","affiliation":[{"name":"The Quzhou Affiliated Hospital of Wenzhou Medical University, Department of Infectious Diseases, Quzhou City, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3964","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Bhagoowani S, Devi U, Munir A, Hasnain U, Iqbal J. Antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis in chronic Hepatitis B: Unraveling the immune puzzle - a rare case report with review of literature. IDCases 2024 Oct 17; 38: e02100. doi: 10.1016\/j.idcr.2024.e02100. PMID: 39469501; PMCID: PMC11513519;","DOI":"10.1016\/j.idcr.2024.e02100"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Shen Y, Wu SD, Chen Y, Li XY, Zhu Q, Nakayama K, Zhang WQ, Weng CZ, Zhang J, Wang HK, Wu J, Jiang W. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response. Gut Microbes 2023 Jan-Dec; 15(1): 2155018. doi: 10.1080\/19490976.2022.2155018. PMID: 36519342; PMCID: PMC9757487;","DOI":"10.1080\/19490976.2022.2155018"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Wong YJ, Nguyen VH, Yang HI, Li J, Le MH, Wu WJ, Han NX, Fong KY, Chen E, Wong C, Rui F, Xu X, Xue Q, Hu XY, Leow WQ, Goh GB, Cheung R, Wong G, Wong VW, Yu MW, Nguyen MH. Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis. Clin Mol Hepatol 2023 Jul; 29(3): 705-20. doi: 10.3350\/cm h.2023.0004. Epub 2023 May 8. PMID: 37157776; PMCID: PMC10366810;","DOI":"10.3350\/cmh.2023.0004"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Wu L, Yang L, Qian X, Hu W, Wang S, Yan J. Mannan-Decorated Lipid Calcium Phosphate Nanoparticle Vaccine Increased the Antitumor Immune Response by Modulating the Tumor Microenvironment. J Funct Biomater 2024 Aug 16; 15(8): 229. doi: 10.3390\/jfb15080229. PMID: 39194667; PMCID: PMC11355305;","DOI":"10.3390\/jfb15080229"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Huang SC, Kao JH. Metabolic dysfunction-associated fatty liver disease and chronic hepatitis B. J Formos Med Assoc 2022 Nov; 121(11): 2148-51. doi: 10.1016\/j.jfm a.2022.07.013. Epub 2022 Aug 15. PMID: 35981929;","DOI":"10.1016\/j.jfma.2022.07.013"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Jiang T, Leng W, Zhong S. Diagnostic Role of Circulating miRNAs in the Grading of Chronic Hepatitis B-Related Liver Fibrosis: A Systematic Review and Meta-Analysis. Lab Med 2023 Sep 5; 54(5): 479-88. doi: 10.1093\/labmed\/lmac151. PMID: 36637253;","DOI":"10.1093\/labmed\/lmac151"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Stalla F, Armandi A, Marinoni C, Fagoonee S, Pellicano R, Caviglia GP. Chronic hepatitis B virus infection and fibrosis: novel noninvasive approaches for diagnosis and risk stratification. Minerva Gastroenterol (Torino) 2022 Sep; 68(3): 306-18. doi: 10.23736\/S2724-5985.21.02911-9. Epub 2021 Apr 19. PMID: 33871225;","DOI":"10.23736\/S2724-5985.21.02911-9"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Wu L, Zhong Y, Yu X, Wu D, Xu P, Lv L, Ruan X, Liu Q, Feng Y, Liu J, Li X. Selective poly adenylation predicts the efficacy of immunotherapy in patients with lung adenocarcinoma by multiple omics research. Anticancer Drugs 2022 Oct 1; 33(9): 943-59. doi: 10.1097\/CAD.00000000000001319. Epub 2022 Aug 9. PMID: 35946526; PMCID: PMC9481295;","DOI":"10.1097\/CAD.0000000000001319"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Liguori A, Zoncap\u00e8 M, Casazza G, Easterbrook P, Tsochatzis EA. Staging liver fibrosis and cirrhosis using noninvasive tests in people with chronic hepatitis B to inform WHO 2024 guidelines: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2025 Apr; 10(4): 332-349. doi: 10.1016\/S2468-1253(24)00437-0. Epub 2025 Feb 18. PMID: 39983746;","DOI":"10.1016\/S2468-1253(24)00437-0"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Lin MH, Li HQ, Zhu L, Su HY, Peng LS, Wang CY, He CP, Liang XE, Wang Y. Liver Fibrosis in the Natural Course of Chronic Hepatitis B Viral Infection: A Systematic Review with Meta-Analysis. Dig Dis Sci 2022 Jun; 67(6): 2608-26. doi: 10.1007\/s10620-021-07009-y. Epub 2021 May 18. PMID: 34008117;","DOI":"10.1007\/s10620-021-07009-y"},{"key":"#cr-split#-ref11.1","doi-asserted-by":"crossref","unstructured":"Chen N, Sun Y, Luo P, Tang Y, Fan Y, Han L, Wang K. Association of CXCR4 gene expression and promoter methylation with chronic hepatitis B-related fibrosis\/cirrhosis. Int Immunopharmacol 2024 Sep 30","DOI":"10.1016\/j.intimp.2024.112686"},{"key":"#cr-split#-ref11.2","doi-asserted-by":"crossref","unstructured":"139: 112686. doi: 10.1016\/j.intimp.2024.112686. Epub 2024 Jul 25. PMID: 39053226;","DOI":"10.1016\/j.intimp.2024.112686"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Kim GA, Choi SW, Han S, Lim YS. Nonlinear association between liver fibrosis scores and viral load in patients with chronic hepatitis B. Clin Mol Hepatol 2024 Oct; 30(4): 793-806. doi: 10.3350\/cm h.2024.0252. Epub 2024 Jul 19. PMID: 39026397; PMCID: PMC11540400;","DOI":"10.3350\/cmh.2024.0252"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Wu L, Zheng Y, Liu J, Luo R, Wu D, Xu P, Wu D, Li X. Comprehensive evaluation of the efficacy and safety of LPV\/r drugs in the treatment of SARS and MERS to provide potential treatment options for COVID-19. Aging (Albany NY) 2021 Apr 20; 13(8): 10833-52. doi: 10.18632\/aging.202860. Epub 2021 Apr 20. PMID: 33879634; PMCID: PMC8109137;","DOI":"10.18632\/aging.202860"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Fan R, Li G, Yu N, Chang X, Arshad T, Liu WY, Chen Y, Wong GL, Jiang Y, Liang X, Chen Y, Jin XZ, Dong Z, Leung HH, Wang XD, Zeng Z, Yip TC, Xie Q, Tan D, Yau S, Ji D, Zhao J, Sanyal AJ, Sun J, Zheng MH, Wong VW, Yang Y, Hou J. aMAP Score and Its Combination With Liver Stiffness Measurement Accurately Assess Liver Fibrosis in Chronic Hepatitis B Patients. Clin Gastroenterol Hepatol 2023 Nov; 21(12): 3070-9.e13. doi: 10.1016\/j.cgh.2023.03.005. Epub 2023 Mar 17. PMID: 36933605;","DOI":"10.1016\/j.cgh.2023.03.005"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Kavak S, Kaya S, Senol A, Sogutcu N. Evaluation of liver fibrosis in chronic hepatitis B patients with 2D shear wave elastography with propagation map guidance: a single-center study. BMC Med Imaging 2022 Mar 18; 22(1): 50. doi: 10.1186\/s12880-022-00777-7. PMID: 35303822; PMCID: PMC8932279;","DOI":"10.1186\/s12880-022-00777-7"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Wu L, Zhong Y, Wu D, Xu IP, Ruan X, Yan J, Liu J, Li X. Immunomodulatory Factor TIM3 of Cytolytic Active Genes Affected the Survival and Prognosis of Lung Adenocarcinoma Patients by Multi-Omics Analysis. Biomedicines 2022 Sep 10; 10(9): 2248. doi: 10.3390\/biomedicines10092248. PMID: 36140350; PMCID: PMC9496572;","DOI":"10.3390\/biomedicines10092248"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Wu L, Li H, Liu Y, Fan Z, Xu J, Li N, Qian X, Lin Z, Li X, Yan J. Research progress of 3D-bioprinted functional pancreas and in vitro tumor models. International Journal of Bioprinting 2024, 10(1), 1256. doi: 10.36922\/ijb.1256;","DOI":"10.36922\/ijb.1256"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Zhou L, Wu CY, Wang XT, Liu SQ, Zhang YZ, Sun YM, et al. Traditional chinese medicine synonymous term conversion: A bidirectional encoder representations from transformers-based model for converting synonymous terms in traditional chinese medicine. World J Tradit Chin Med 2023; 9: 224-33. doi: 10.4103\/2311-8571.378171;","DOI":"10.4103\/2311-8571.378171"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Dilcan KH, Gozdas HT. Noninvasive evaluation of significant liver fibrosis in chronic hepatitis B patients. Acta Gastroenterol Belg 2024 Jul-Sep; 87(3): 388-92. doi: 10.51821\/87.3.13290. PMID: 39411792;","DOI":"10.51821\/87.3.13290"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Wu L, Liu Q, Ruan X, Luan X, Zhong Y, Liu J, Yan J, Li X. Multiple Omics Analysis of the Role of RBM10 Gene Instability in Immune Regulation and Drug Sensitivity in Patients with Lung Adenocarcinoma (LUAD). Biomedicines 2023 Jun 29; 11(7):1861. doi: 10.3390\/biomedicines11071861. PMID: 37509501; PMCID: PMC10377220;","DOI":"10.3390\/biomedicines11071861"},{"key":"ref21","unstructured":"Wang WM, Zhang WS, Yang ZG. Vimentin (VIM) predicts advanced liver fibrosis in chronic hepatitis B patients: A random forest-derived analysis. Eur Rev Med Pharmacol Sci 2022 Jul; 26(14): 5164-77. doi: 10.26355\/eurrev_202207_29305. PMID: 35916814;"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Wu L, Li X, Qian X, Wang S, Liu J, Yan J. Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity. Vaccines (Basel) 2024 Feb 12; 12(2): 186. doi: 10.3390\/vaccines12020186. PMID: 38400169; PMCID: PMC10891594;","DOI":"10.3390\/vaccines12020186"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Wu L, Zheng Y, Ruan X, Wu D, Xu P, Liu J, Wu D, Li X. Long-chain noncoding ribonucleic acids affect the survival and prognosis of patients with esophageal adenocarcinoma through the autophagy pathway: construction of a prognostic model. Anticancer Drugs 2022 Jan 1; 33(1): e590-e603. doi: 10.1097\/CAD.0000000000001189. PMID: 34338240; PMCID: PMC8670349;","DOI":"10.1097\/CAD.0000000000001189"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Pan Z, Li Z, Meng F, Hu Y, Zhang X, Chen Y. Fatand iron-corrected ADC to assess liver fibrosis in patients with chronic hepatitis B. Diagn Interv Radiol 2022 Jan; 28(1): 5-11. doi: 10.5152\/dir.2021.21471. PMID: 34914604; PMCID: PMC12278920;","DOI":"10.5152\/dir.2021.21471"},{"key":"ref25","unstructured":"Luu NM, Nguyen TKT, Vu TT, Dinh TS, Luu NH, Do TTT, Nguyen VS, Ha TBV, Nguyen DC, Tran TH, Phung TTH, Duong XP, Khuong QL, Nguyen TTT, Saw YM, Hoang TNA, Nguyen TN. Progression of liver fibrosis and associated factors among chronic hepatitis B patients at a general hospital in Northern Vietnam. Nagoya J Med Sci 2022 Feb; 84(1): 19-28. doi: 10.18999\/nagjms.84.1.19. PMID: 35392005; PMCID: PMC8971045;"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Bui HH, Nguyen ST, Phan ST, Nguyen KM, Nguyen CD. Evaluating M2BPGi as a Marker for Liver Fibrosis in Patients with Chronic Hepatitis B. Dig Dis Sci 2023 Dec; 68(12): 4407-17. doi: 10.1007\/s10620-023-08143-5. Epub 2023 Oct 20. PMID: 37861877; PMCID: PMC10635958;","DOI":"10.1007\/s10620-023-08143-5"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Wu L, Chen X, Zeng Q, Lai Z, Fan Z, Ruan X, Li X, Yan J. NR5A2 gene affects the overall survival of LUAD patients by regulating the activity of CSCs through SNP pathway by OCLR algorithm and immune score. Heliyon 2024 Mar 28; 10(7): e28282. doi: 10.1016\/j.heliyon.2024.e28282. PMID: 38601554; PMCID: PMC11004709;","DOI":"10.1016\/j.heliyon.2024.e28282"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Yang K, Pan Y, Liu L, Sun B, Shi W. Serum Alpha-Fetoprotein as a Predictor of Liver Fibrosis in HBeAg-Positive Chronic Hepatitis B Patients. Medicina (Kaunas) 2023 May 11; 59(5): 923. doi: 10.3390\/medicina59050923. PMID: 37241155; PMCID: PMC10221886;","DOI":"10.3390\/medicina59050923"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Han BJ, Liu YJ, Jin JY, Xu HK, Zhang WZ, Ren SM, et al. Symptom assessment and management in patients with lung cancer undergoing conventional or traditional chinese medicine care. World J Tradit Chin Med 2023; 9: 235-42. doi: 10.4103\/2311-8571.382112;","DOI":"10.4103\/2311-8571.382112"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Sohn W, Chang Y, Cho YK, Hong YS, Shin H, Ryu S. Liver fibrosis scores and risk of liver-related mortality in young adults with chronic hepatitis B: A cohort study. J Viral Hepat 2022 Jan; 29(1): 69-77. doi: 10.1111\/jvh.13618. Epub 2021 Oct 7. PMID: 34582599;","DOI":"10.1111\/jvh.13618"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Zhang X, Wan Z, Lin M, Li Y, Wu X, Jiang J, Lin S, Chi X. Immunoglobulin A and complement C4 are involved in the progression of liver fibrosis in patients with chronic hepatitis B. Int Immunopharmacol 2023 Sep; 122: 110604. doi: 10.1016\/j.intimp.2023.110604. Epub 2023 Jul 12. PMID: 37451022;","DOI":"10.1016\/j.intimp.2023.110604"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Chen N, Luo P, Tang Y, Liu P, Wang J, Fan Y, Han L, Wang K. Accelerators of chronic hepatitis B fibrosis cirrhosis CCND1 gene expression and promoter hypomethylation. Sci Rep 2025 Mar 27; 15(1): 10630. doi: 10.1038\/s41598-025-93778-9. PMID: 40148411; PMCID: PMC11950333;","DOI":"10.1038\/s41598-025-93778-9"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Wu L, Li X, Yan J. Commentary: Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma. Transl Oncol 2024 Jul; 45: 101995. doi: 10.1016\/j.tranon.2024.101995. Epub 2024 May 9. PMID: 38789241;","DOI":"10.1016\/j.tranon.2024.101995"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Sapmaz FP, B\u00fcy\u00fckturan G, Sakin YS, Kalkan H, Atasoy P. How effective are APRI, FIB-4, FIB-5 scores in predicting liver fibrosis in chronic hepatitis B patients? Medicine (Baltimore) 2022 Sep 9; 101(36): e30488. doi: 10.1097\/MD.0000000000030488. PMID: 36086763; PMCID: PMC10980425;","DOI":"10.1097\/MD.0000000000030488"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Liu Z, Wen H, Zhu Z, Li Q, Liu L, Li T, Xu W, Hou C, Huang B, Li Z, Dong C, Chen X. Diagnosis of significant liver fibrosis in patients with chronic hepatitis B using a deep learning-based data integration network. Hepatol Int 2022 Jun; 16(3): 526-36. doi: 10.1007\/s12072-021-10294-4. Epub 2022 Mar 21. PMID: 35312969;","DOI":"10.1007\/s12072-021-10294-4"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Liao MJ, Li J, Dang W, Chen DB, Qin WY, Chen P, Zhao BG, Ren LY, Xu TF, Chen HS, Liao WJ. Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China. World J Gastroenterol 2022 Jul 21; 28(27): 3503-13. doi: 10.3748\/wjg.v28.i27.3503. PMID: 36158257; PMCID: PMC9346453;","DOI":"10.3748\/wjg.v28.i27.3503"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Ekmen MO, Uzman M. The Relationship between Mean Platelet Volume and Neutrophil-Lymphocyte Ratio and Liver Fibrosis in Patients with Chronic Hepatitis B. Medicina (Kaunas) 2023 Jul 12; 59(7): 1287. doi: 10.3390\/medicina59071287. PMID: 37512098; PMCID: PMC10384412;","DOI":"10.3390\/medicina59071287"}],"container-title":["Journal of Medical Biochemistry"],"original-title":["Analiza korelacije izme\u0111u Th1\/Th2 citokina i pokazatelja fibroze jetre kod pacijenata sa hroni\u010dnim hepatitisom tipa B"],"language":"en","link":[{"URL":"https:\/\/scindeks-clanci.ceon.rs\/data\/pdf\/1452-8258\/2026\/1452-82582604749Y.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T14:19:41Z","timestamp":1776262781000},"score":1,"resource":{"primary":{"URL":"https:\/\/scindeks.ceon.rs\/Article.aspx?artid=1452-82582604749Y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5937\/jomb0-60938","relation":{},"ISSN":["1452-8258","1452-8266"],"issn-type":[{"value":"1452-8258","type":"print"},{"value":"1452-8266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}